MX355853B - Composicion oftalmica para el tratamiento de infeccion ocular. - Google Patents

Composicion oftalmica para el tratamiento de infeccion ocular.

Info

Publication number
MX355853B
MX355853B MX2016016090A MX2016016090A MX355853B MX 355853 B MX355853 B MX 355853B MX 2016016090 A MX2016016090 A MX 2016016090A MX 2016016090 A MX2016016090 A MX 2016016090A MX 355853 B MX355853 B MX 355853B
Authority
MX
Mexico
Prior art keywords
ophthalmic composition
treatment
ocular infection
ocular
infection
Prior art date
Application number
MX2016016090A
Other languages
English (en)
Other versions
MX2016016090A (es
Inventor
C Si Erwin
Original Assignee
Coopervision Int Holding Co Lp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Coopervision Int Holding Co Lp filed Critical Coopervision Int Holding Co Lp
Publication of MX2016016090A publication Critical patent/MX2016016090A/es
Publication of MX355853B publication Critical patent/MX355853B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a una composición oftálmica para administración a un ojo de un paciente para el tratamiento de una infección ocular. La composición oftálmica contiene una ?-polilisina (?P) en una cantidad efectiva para tratar o controlar o evitar la infección ocular.
MX2016016090A 2014-06-20 2015-06-18 Composicion oftalmica para el tratamiento de infeccion ocular. MX355853B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462014777P 2014-06-20 2014-06-20
PCT/GB2015/051790 WO2015193677A1 (en) 2014-06-20 2015-06-18 Ophthalmic composition for the treatment of ocular infection

Publications (2)

Publication Number Publication Date
MX2016016090A MX2016016090A (es) 2017-07-13
MX355853B true MX355853B (es) 2018-05-02

Family

ID=53539736

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016016090A MX355853B (es) 2014-06-20 2015-06-18 Composicion oftalmica para el tratamiento de infeccion ocular.

Country Status (13)

Country Link
US (1) US9789058B2 (es)
EP (1) EP3157507B1 (es)
JP (1) JP6200108B2 (es)
KR (1) KR20170014006A (es)
CN (1) CN106456710A (es)
AU (1) AU2015275896B2 (es)
CA (1) CA2952772C (es)
GB (1) GB2541840B (es)
HU (1) HUE047107T2 (es)
MX (1) MX355853B (es)
MY (1) MY177504A (es)
SG (1) SG11201610062YA (es)
WO (1) WO2015193677A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3106172T3 (pl) * 2015-06-15 2020-12-28 B. Braun Melsungen Ag Środek aktywny przeciwdrobnoustrojowo i jego zastosowanie
KR101962882B1 (ko) 2017-06-01 2019-03-28 한국과학기술연구원 구연산염 검출 센서 및 이를 이용한 구연산염 검출 방법
US11129862B2 (en) * 2017-08-30 2021-09-28 Johnson & Johnson Consumer Inc. Ophthalmic compositions
CN111202746B (zh) * 2020-02-27 2021-03-16 潍坊医学院附属医院 一种眼用复合制剂及其制备方法
CN111840225B (zh) * 2020-08-12 2021-09-14 陈丽娜 一种用于治疗青光眼的滴眼剂及其制备方法
TWI815436B (zh) * 2022-05-10 2023-09-11 長庚大學 使用聚離胺酸奈米粒子來治療乾眼症

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4730013A (en) 1981-10-08 1988-03-08 Merck & Co., Inc. Biosoluble ocular insert
CN1259976C (zh) * 1996-02-02 2006-06-21 旭化成爱眼株式会社 隐形眼镜的保存消毒用溶液
US6239113B1 (en) 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
JP2001261552A (ja) * 2000-03-22 2001-09-26 Chisso Corp 点眼液用保存剤
JP2002020320A (ja) * 2000-06-30 2002-01-23 Santen Pharmaceut Co Ltd 点眼液用防腐剤
KR20040080923A (ko) 2002-02-07 2004-09-20 가부시키가이샤 오프테꾸스 콘택트 렌즈용 액제
AU2003222049B2 (en) * 2002-03-21 2007-05-31 Cayman Chemical Company, Incorporated Prostaglandin F2 alpha analogs in combination with antimicrobials for treating glaucoma
JP2006201247A (ja) * 2005-01-18 2006-08-03 Taki Chem Co Ltd コンタクトレンズ用消毒保存溶液
CN101822736A (zh) 2010-03-08 2010-09-08 深圳市倍安蒂科技有限公司 一种新型生物杀菌剂及其制备方法
JP2011245053A (ja) * 2010-05-27 2011-12-08 Nanyang Technological Univ 眼用及び医療用の重合性組成物及びそれを重合して得られる抗菌性組成物
EP2603587B1 (en) * 2010-08-09 2015-10-07 INSERM (Institut National de la Santé et de la Recherche Médicale) Pharmaceutical compositions for the treatment and prevention of hiv-1 infections
CN101954113B (zh) 2010-08-13 2014-03-19 北京赛奇科科技有限公司 可防止眼外科手术后感染和渗漏的凝胶涂敷套件
CN103370087A (zh) * 2011-01-19 2013-10-23 目立康株式会社 隐形眼镜用液体制剂
US20120215184A1 (en) 2011-02-18 2012-08-23 Valeant International (Barbados) Srl Cylindrical ocular inserts
US20120277239A1 (en) * 2011-04-28 2012-11-01 Alpha Synergy Development Inc. Compositions and Methods for Improving Night Vision
US20140178327A1 (en) 2012-12-21 2014-06-26 Coopervision International Holding Company, Lp Antimicrobial Ophthalmic Devices
JP6260042B2 (ja) 2013-05-27 2018-01-17 学校法人玉川学園 抗アカントアメーバ用組成物及び該抗アカントアメーバ用組成物を含有する眼科用剤

Also Published As

Publication number Publication date
KR20170014006A (ko) 2017-02-07
HUE047107T2 (hu) 2020-04-28
AU2015275896A1 (en) 2017-01-12
CA2952772A1 (en) 2015-12-23
WO2015193677A1 (en) 2015-12-23
US20170196805A1 (en) 2017-07-13
GB2541840B (en) 2017-09-06
GB201621904D0 (en) 2017-02-01
CA2952772C (en) 2018-06-12
EP3157507A1 (en) 2017-04-26
JP2017518332A (ja) 2017-07-06
CN106456710A (zh) 2017-02-22
EP3157507B1 (en) 2019-07-31
US9789058B2 (en) 2017-10-17
SG11201610062YA (en) 2016-12-29
MY177504A (en) 2020-09-17
AU2015275896B2 (en) 2017-05-18
JP6200108B2 (ja) 2017-09-20
GB2541840A (en) 2017-03-01
MX2016016090A (es) 2017-07-13

Similar Documents

Publication Publication Date Title
HK1222116A1 (zh) 用於治療青光眼的能夠植入患者的眼睛內的改善的排液閥
MX355853B (es) Composicion oftalmica para el tratamiento de infeccion ocular.
MY171920A (en) Prevention and treatment of ocular conditions
MX2018006171A (es) Jeringa de plastico precargada que contiene un antagonista de vegf.
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
EP3324890A4 (en) GLACO-TREATMENT VIA INTRAKAMERAL EYE IMPLANTS
IL282504A (en) Ocular formulations for drug administration and protection of the front part of the eye
MX2020003534A (es) Composiciones oftalmicas que comprenden latanoprost para usarse en el tratamiento de las enfermedades oculares.
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
EP3738559B8 (de) System zur augentherapie mittels gewebebearbeitung durch nichtlineare wechselwirkung
MX2019011925A (es) Conjugados y derivados de prostaglandina para tratar el glaucoma y la hipertension ocular.
ZA202003944B (en) Ophthalmic topical composition comprising dobesilic acid for treating diseases of the posterior segment of the eye
EP3302382A4 (en) IMPLANT FOR THE TREATMENT OF OCULAR DISEASE
PL3407879T3 (pl) Gabapentyna okulistyczna do leczenia wrzodów rogówki
BR112017007102A2 (pt) uso de um medicamento no tratamento de patologias da córnea, composição oftálmica para uso de um medicamento no tratamento de doenças da córnea e método para preparar a composição oftálmica
SG10201903630UA (en) Iminosugars useful for the treatment of viral diseases
IL269133A (en) Eye drops for the treatment of irritation without infection
PH12016502111A1 (en) Drug for treatment of tinnitus patients

Legal Events

Date Code Title Description
FG Grant or registration